What To Do When Traditional Treatments for Depression Fail
Treatment Resistant Depression is Common and Crippling
The symptoms of depression can be crippling for those who suffer from this illness. Depression can interfere with your daily activities, causing persistent feelings of sadness, loss of interest, and hope. In the worst cases, some people feel as if life isn’t worth living anymore. Major depressive disorder (MDD) is a debilitating illness associated with frequent relapses, persistent symptoms, and incomplete recovery.
Luckily, there are many effective treatments available for depression such as SSRIs, SNRIs and other new generation antidepressants. But, unfortunately, for one-third of U.S. patients with depression, standard medications aren’t enough.
Treatment-Resistant Depression
To start, it’s important to understand the term treatment-resistant when dealing with depression. An estimated 1 in 6 Americans will develop major depression in their lifetime and many will find relief in standard depression treatments such as medications, CBT, and/or interpersonal therapy. Other treatments like ECT, rTMS, VNS and DBS are sometimes helpful, too.
But what about the estimated 30% of patients who still can’t find relief? Ketamine and Esketamine (Spravato) could be the answer.
The Science Behind Ketamine and Esketamine (Spravato)
Ketamine and Esketamine (Spravato) has long been used in the medical field as an FDA approved anesthetic. Now, research shows evidence of innovative uses for ketamine such as in treating difficult -to- treat cases of depression. In fact, up to 75% of patients who suffer from treatment resistant psychiatric illnesses do experience quick and substantial relief after receiving ketamine infusions.
The Complexity of Depression
The truth is, depression is a very complex illness. It’s so much more than just a chemical imbalance. There are millions of chemical reactions that make up the system that is responsible for your mood and how you feel. This is why it’s crucial to receive top-notch care especially when dealing with treatment-resistant cases of depression.
COPE Centers Provide Top-Notch Care
COPE was founded by three internationally renowned psychiatrists with over 60 years of clinical and academic experiences. They saw a clear, unmet need to provide support and services to facilities that offer evidence-based, innovative treatments for two of the most common medical illnesses in the world.
Because of the complexity of depression, its debilitating symptoms, and the life-changing benefits of Ketamine and Esketamine (Spravato), it’s important to find the right care. Look no further than one of our conveniently located centers in (list all cities for SEO).